Showing posts with label weight loss. Show all posts
Showing posts with label weight loss. Show all posts

Saturday, 26 March 2011

Illegal online pharmacies dealing in fake drugs

Sixty two percent of medicines purchased over the internet are either substandard or fake, according to a new report.
The watchdog Irish Medicines Board (IMB) in 2007 seized nearly 200,000 illegally imported tablets and capsules, including anabolic steroids, anti-impotence drugs and weight loss products.
The report, based on an analysis of more than 100 online pharmacies, examined the medicines which were delivered without need of prescription. It revealed:
- 95.6pc of online pharmacies researched are operating illegally.
- 94pc of websites do not have a named, verifiable pharmacist.
- Over 90pc of websites supply prescription-only medicines without a prescription.
- 86pc of online 'pharmacy approval' stamps are fake.
- There is a three in five chance of receiving a fake or substandard medicine if you purchase online.
- Only 38pc of the medicines received were found to be genuine, branded medicines, 16pc of these were illegal non-EU imports (genuine products, imported into the EU illegally from a non-EU country), and 33pc did not have patient information leaflets.
The findings are contained in the report of the European Alliance for Access to Safe Medicines (EAASM).

Sunday, 19 December 2010

Callum Priestley tested positive

Callum Priestley, the 21-year-old sprint hurdler, who won the 60m hurdles title at the British trials, has become the first athlete to fail a drug test after Dwain Chambers tested positive for Tetrahydrogestrinone in 2003.
Priestley was provisionally suspended from all competition and funding after his provided B sample tested positive for clenbuterol.
The UKA chief executive, Niels de Vos, said: "I am hugely disappointed that there has been a failed test. UKA continues to give 100% support to the work of UK Anti-Doping and we maintain our full commitment to drug-free sport."
Priestley's positive sample turned up following an out-of-competition test taken at a UKA training camp in South Africa in January. If found guilty he will face a two-year ban and a lifetime ban from competing as a British athlete in the Olympic Games.
Clenbuterol is on the World Anti-Doping Authority's banned substance list for its performance enhancing properties that include improved aerobic capacity and a faster metabolism that helps with weight loss. In 2008, the American swimmer Jessica Hardy was forced to withdraw from the US Olympic team after testing positive for the drug, while Poland's sprint canoeist Adam Seroczynski, who also tested positive, was disqualified from the K-2 1,000m event at the Beijing Olympic Games and subsequently banned from the sport for two years.
Clenbuterol is an ingredient in drugs prescribed to patients afflicted from chronic breathing disorders like asthma.

Tuesday, 26 October 2010

Hydroxycut diet aids recalled


Citing reports of a death due to liver failure and other instances of serious health problems, the Federal drug regulators have warned consumers not to use the Hydroxycut line of weight loss products.
The FDA said that it had received twenty three reports of significant adverse health effects such as heart problems, muscle damage, and kidney damage in people making use of Hydroxycut.
The Hydroxycut brand, which has been widely sold at national chain stores including GNC and the Vitamin Shoppe, includes pills, drinks and powders marketed to increase energy, burn calories and fat, and control appetite. The maker reported selling more than nine million units of the brand last year, according to the F.D.A.
That company, Iovate Health Sciences of Oakville, Ontario, and its American distributor are voluntarily recalling 14 of the products. Two other products, Hydroxycut Cleanse and Hoodia, with different ingredients, are not affected by the recall. Calls to the company’s Canadian headquarters reached a recorded message that directed callers to the Hydroxycut Web site.
The recall of one of the best-known weight-loss brands is the latest in a series of incidents that raise the question of whether the Food and Drug Administration has adequate authority to regulate the dietary supplement industry and provide consumer protection.
At issue is the difference in the way the agency oversees drugs — defined as products that prevent or cure disease — and dietary supplements, which can offer general health benefits but cannot claim to treat specific diseases or symptoms.
Part of the problem is that the FDA looks at dietary supplements from a postmarket perspective and a single incident is often difficult to follow, according to Dr. Linda Katz, interim chief medical officer of the agency’s Center for Food Safety and Applied Nutrition.